Cookies?
Library Header Image
LSE Research Online LSE Library Services

Treatment gap for anxiety disorders is global: results of the World Mental Health Surveys in 21 countries

Alonso, Jordi and Liu, Zhaorui and Evans-Lacko, Sara and Sadikova, Ekaterina and Sampson, Nancy and Chatterji, Somnath and Abdulmalik, Jibril O. and Aguilar-Gaxiola, Sergio and Al-Hamzawi, Ali and Andrade, Laura H. and Bruffaerts, Ronny and Cardoso, Graça and Cia, Alfredo and Florescu, Silvia and de Girolamo, Giovanni and Gureje, Oye and Haro, Josep M. and He, Yanling and de Jonge, Peter and Karam, Elie G. and Kawakami, Norito and Kovess-Masfety, Viviane and Lee, Sing and Levinson, Daphna and Medina-Mora, Maria Elena and Navarro-Mateu, Fernando and Pennell, Beth-Ellen and Piazza, Marina and Posada-Villa, Jose and ten Have, Margreet and Zarkov, Zahari and Kessler, Ronald C. and Thornicroft, Graham (2018) Treatment gap for anxiety disorders is global: results of the World Mental Health Surveys in 21 countries. Depression and Anxiety, 35 (3). pp. 195-208. ISSN 10914269

[img] Text - Accepted Version
Restricted to Repository staff only until 22 January 2019.

Download (715kB) | Request a copy
Identification Number: 10.1002/da.22711

Abstract

1 Background: Anxiety disorders are a major cause of burden of disease. Treatment gaps have been described, but a worldwide evaluation is lacking. We estimated, among individuals with a 12‐month DSM‐IV (where DSM is Diagnostic Statistical Manual) anxiety disorder in 21 countries, the proportion who (i) perceived a need for treatment; (ii) received any treatment; and (iii) received possibly adequate treatment. 2 Methods: Data from 23 community surveys in 21 countries of the World Mental Health (WMH) surveys. DSM‐IV mental disorders were assessed (WHO Composite International Diagnostic Interview, CIDI 3.0). DSM‐IV included posttraumatic stress disorder among anxiety disorders, while it is not considered so in the DSM‐5. We asked if, in the previous 12 months, respondents felt they needed professional treatment and if they obtained professional treatment (specialized/general medical, complementary alternative medical, or nonmedical professional) for “problems with emotions, nerves, mental health, or use of alcohol or drugs.” Possibly adequate treatment was defined as receiving pharmacotherapy (1+ months of medication and 4+ visits to a medical doctor) or psychotherapy, complementary alternative medicine or nonmedical care (8+ visits). 3 Results: Of 51,547 respondents (response = 71.3%), 9.8% had a 12‐month DSM‐IV anxiety disorder, 27.6% of whom received any treatment, and only 9.8% received possibly adequate treatment. Of those with 12‐month anxiety only 41.3% perceived a need for care. Lower treatment levels were found for lower income countries. 4 Conclusions: Low levels of service use and a high proportion of those receiving services not meeting adequacy standards for anxiety disorders exist worldwide. Results suggest the need for improving recognition of anxiety disorders and the quality of treatment.

Item Type: Article
Official URL: https://onlinelibrary.wiley.com/journal/15206394
Additional Information: © 2018 John Wiley & Sons
Subjects: R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Sets: Research centres and groups > Personal Social Services Research Unit (PSSRU)
Date Deposited: 20 Apr 2018 09:27
Last Modified: 20 Apr 2018 09:33
URI: http://eprints.lse.ac.uk/id/eprint/87584

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics